Pateres, Mhark Ghiell R.

HRN: 22-24-69  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/20/2023
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
01/21/2023
01/23/2023
INTRAVENOUS
15 Mg
Q24 X 3 Days
Sepsis, Unspecified
Waiting Final Action 

Indication:  Empiric    Type of Infection:  Unspecified Sepsis    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: